SCHEMBL31350484

SCHEMBL31350484

Cc1cc(C)c2c(N)cc(Cl)nc2n1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 8/20 0.45
ALDH1A1 P00352 6/20 0.45
POLB P06746 5/20 0.45
HPGD P15428 5/20 0.45
SMN1; SMN2 Q16637 5/20 0.45
LMNA P02545 4/20 0.45
HTT P42858 4/20 0.45
RAD52 P43351 3/20 0.45
KMT2A Q03164 3/20 0.45
MITF O75030 2/20 0.45
CYP1A2 P05177 2/20 0.45
CYP2C19 P33261 2/20 0.45
GAA P10253 1/20 0.45
CYP2D6 P10635 1/20 0.45
MAPT P10636 3/20 0.44
MEN1 O00255 1/20 0.44
PSMD14 O00487 1/20 0.44
APEX1 P27695 1/20 0.44
RAB9A P51151 1/20 0.44
CASP1 P29466 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31350703 0.81 ALDH1A1 (0.44) KDM4EALDH1A1POLBHPGDSMN1; SMN2
SCHEMBL31350459 0.75 ALDH1A1 (0.36) KDM4EALDH1A1POLBHPGDSMN1; SMN2
SCHEMBL31350740 0.74 KDM4E (0.49) KDM4EALDH1A1POLBHPGDSMN1; SMN2
SCHEMBL31350638 0.74 KDM4E (0.45) KDM4EALDH1A1POLBHPGDSMN1; SMN2
SCHEMBL13622765 0.70 ADORA1 (0.57) KDM4EPOLBLMNAKMT2ACYP1A2
SCHEMBL5434647 0.70 KDM4E (0.41) KDM4EKMT2ACYP1A2CYP2C19MAPT
SCHEMBL14520700 0.69 KDM4E (0.58) KDM4EALDH1A1POLBHPGDSMN1; SMN2
SCHEMBL31350720 0.69 ALDH1A1 (0.40) KDM4EALDH1A1POLBHPGDSMN1; SMN2
SCHEMBL31350697 0.68 ALDH1A1 (0.39) KDM4EALDH1A1POLBHPGDSMN1; SMN2
SCHEMBL11543194 0.66 NR4A2 (0.51) KDM4EALDH1A1POLBHPGDSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4743462-A1 COMPOUNDS COMPRISING A NAPHTHYRIDINE OR PYRIDOPYRIMIDINE CORE AS PTC READ-THROUGH AGENTS Tay Therapeutics Limited (GB) 2026-05-20 EP disclosed
WO-2025133613-A1 COMPOUNDS COMPRISING A NAPHTHYRIDINE OR PYRIDO-PYRIMIDINE CORE AND A (HETERO)AROMATIC-AMINO SUBSTITUENT Tay Therapeutics Limited (GB) 2025-06-26 WO disclosed
WO-2025012643-A1 COMPOUNDS COMPRISING A NAPHTHYRIDINE OR PYRIDOPYRIMIDINE CORE AS PTC READ-THROUGH AGENTS Tay Therapeutics Limited (GB) 2025-01-16 WO disclosed